research on glp 1 drugs GLP-1 may aid in substance use disorders The Information Survey: More Than

Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

Griffonia : Griffonia (Griffonia simplicifolia) a plant native to Africa, is renowned for its high content of 5-HTP (5-hydroxytryptophane), a direct precursor of serotonin, commonly referred to as the "happiness hormone." Griffonia is particularly valued for its ability to enhance brain activity and support emotional well-being

The complete solution for natural metabolic support

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

STRESS SUPPORT TO PROMOTE CORTISOL BALANCE* Some studies show that Sensoril Ashwagandha may provide stress support and help promote a balanced cortisol response in certain individuals, which can be important for maintaining a healthy weight